Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

The conclusion is that effectively treating hair disorders is difficult due to the complex factors affecting hair growth and more research is needed to improve treatments.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Different wavelengths of LED light are needed to treat different types of hair loss effectively.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

The combined laser and plasma jet therapy effectively regrew hair in a woman with alopecia areata.

Tetracycline successfully treated a Labrador's skin calcification and hair loss.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

A man had temporary hair loss from radiation during a medical procedure but regrew his hair after treatment with minoxidil lotion.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Post-implantation erythema is a red skin condition after medical device implantation that sometimes goes away on its own.

Fractional lasers seem effective and safe for treating hair loss, but more research is needed to find the best treatment methods.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

The document concludes that correct diagnosis of alopecia types is crucial, scalp biopsies are important, and more research is needed.

Minoxidil modestly increases hair growth in men with early baldness and is safe to use.

Pediatricians should treat some hair loss types in children and refer others to a dermatologist.